82 related articles for article (PubMed ID: 24313208)
1. [Investigation on biological characteristics of CD133+ cancer stem cells in human laryngeal carcinoma Hep-2 cell line].
Wei XD; He J; Gao JX; Wang JY; Ma BJ; Chen J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jul; 48(7):578-83. PubMed ID: 24313208
[TBL] [Abstract][Full Text] [Related]
2. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line.
Wei XD; Zhou L; Cheng L; Tian J; Jiang JJ; Maccallum J
Head Neck; 2009 Jan; 31(1):94-101. PubMed ID: 18853445
[TBL] [Abstract][Full Text] [Related]
3. [Experimental investigation of CD133 as a putative marker of tumor-initiating cell in laryngeal carcinoma].
Wei XD; Zhou L; Cheng L; Tian J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Dec; 41(12):940-4. PubMed ID: 17345710
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of CD133 as putative marker of tumor-initiating cell in laryngeal carcinoma].
Wei XD; Zhou L; Cheng L; Tian J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Sep; 42(9):692-6. PubMed ID: 18051573
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia promotes radioresistance of CD133-positive Hep-2 human laryngeal squamous carcinoma cells in vitro.
Wang M; Li X; Qu Y; Xu O; Sun Q
Int J Oncol; 2013 Jul; 43(1):131-40. PubMed ID: 23652853
[TBL] [Abstract][Full Text] [Related]
6. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS
Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of self-renewal mechanism about CD133+ cancer stem cells in human laryngeal carcinoma Hep-2 cell line].
Wei X; He J; Gao J; Chen J; Wang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Nov; 28(21):1636-41. PubMed ID: 25735089
[TBL] [Abstract][Full Text] [Related]
8. CD133, one of the markers of cancer stem cells in Hep-2 cell line.
Zhou L; Wei X; Cheng L; Tian J; Jiang JJ
Laryngoscope; 2007 Mar; 117(3):455-60. PubMed ID: 17334305
[TBL] [Abstract][Full Text] [Related]
9. [Cancer stem cells play an important role in resistance of laryngeal squamous cancer to irradiation mediated by hypoxia].
Wang MX; Li XM; Zhao Y; Lu XY; Qu YT; Xu O; Sun QJ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec; 46(12):1024-9. PubMed ID: 22336015
[TBL] [Abstract][Full Text] [Related]
10. Glucose transporter-1 expression in CD133+ laryngeal carcinoma Hep-2 cells.
Chen XH; Bao YY; Zhou SH; Wang QY; Wei Y; Fan J
Mol Med Rep; 2013 Dec; 8(6):1695-700. PubMed ID: 24146103
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia promotes stem-like properties of laryngeal cancer cell lines by increasing the CD133+ stem cell fraction.
Wu CP; Du HD; Gong HL; Li DW; Tao L; Tian J; Zhou L
Int J Oncol; 2014 May; 44(5):1652-60. PubMed ID: 24573690
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of BMI-1 in cancer stem cells of laryngeal carcinoma.
Yu D; Liu Y; Yang J; Jin C; Zhao X; Cheng J; Liu X; Qi X
Cell Biochem Biophys; 2015 Jan; 71(1):261-9. PubMed ID: 25241082
[TBL] [Abstract][Full Text] [Related]
13. [Carcinogenicity study of CD133(+)CD44(+) laryngeal cancer stem cells and identification of related microRNAs].
Li Y; Zhou XH; Chen ZH; Dai LL; Cui CX; Wu HL; Wei QY; Fan KM; Xu YL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 54(7):529-533. PubMed ID: 31315361
[No Abstract] [Full Text] [Related]
14. Minnelide effectively eliminates CD133(+) side population in pancreatic cancer.
Nomura A; McGinn O; Dudeja V; Sangwan V; Saluja AK; Banerjee S
Mol Cancer; 2015 Nov; 14():200. PubMed ID: 26597727
[TBL] [Abstract][Full Text] [Related]
15. [Neoplasms stem cells play an important role in resistance of laryngeal squamous cancer to chemoradiotherapy].
Han R; Huangfu H; Gao W; Zhang C; Jin Y; Li Z; Wang B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 28(6):400-5. PubMed ID: 24961129
[TBL] [Abstract][Full Text] [Related]
16. [Isolation and in vitro characterization of CD133(+) side population cells from laryngeal cancer cell line].
Wu CP; Zhou L; Xie M; Tao L; Zhang M; Tian J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Sep; 46(9):752-7. PubMed ID: 22177045
[TBL] [Abstract][Full Text] [Related]
17. [Biological characteristics of highly tumorigenic CD44+CD133+ subpopulation of laryngeal carcinoma cells].
Yu D; Jin CS; Chen O; Wen LJ; Gao LF
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):99-103. PubMed ID: 19538883
[TBL] [Abstract][Full Text] [Related]
18. Bmi-1 is essential for the oncogenic potential in CD133(+) human laryngeal cancer cells.
Wei X; He J; Wang J; Yang X; Ma B
Tumour Biol; 2015 Nov; 36(11):8931-42. PubMed ID: 26081615
[TBL] [Abstract][Full Text] [Related]
19. [Isolation and in vivo tumorigenicity assay of CD133+ side population cells from laryngeal cancer cell line].
Wu CP; Zhou L; Xie M; Tao L; Zhang M; Tian J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):223-7. PubMed ID: 22805024
[TBL] [Abstract][Full Text] [Related]
20. [Lentivirus-mediated RNA interference of CD133 inhibits the proliferation of CD133(+) liver cancer stem cells and increases their cisplatin chemosensitivity].
Lan X; Wang Y; Cao S; Zou D; Li F; Li S
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1741-7. PubMed ID: 23268401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]